世界のソマトスタチン受容体2型市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Somatostatin Receptor Type 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14437 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、ソマトスタチン受容体2型のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ソマトスタチン受容体2型の種類別市場規模（CRN-00808、酢酸ランレオチド、PRL-2903、その他）、用途別市場規模（ホルモン障害、腫瘍、代謝障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ソマトスタチン受容体2型の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amryt Pharma plc、Crinetics Pharmaceuticals Inc、Daewoong Pharmaceutical Co Ltd、Ipsen SA、Progenics Pharmaceuticals Inc、Strongbridge Biopharma plc、Zucara Therapeutics Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CRN-00808、酢酸ランレオチド、PRL-2903、その他 ・用途別分析2016年-2026年：ホルモン障害、腫瘍、代謝障害、その他 ・ソマトスタチン受容体2型の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ソマトスタチン受容体2型のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ソマトスタチン受容体2型のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ソマトスタチン受容体2型の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ソマトスタチン受容体2型の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Somatostatin Receptor Type 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Somatostatin Receptor Type 2 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Somatostatin Receptor Type 2 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Somatostatin Receptor Type 2 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
CRN-00808
Lanreotide Acetate
PRL-2903
Others

Market segment by Application, can be divided into
Hormonal Disorder
Oncology
Metabolic Disorder
Others

Market segment by players, this report covers
Amryt Pharma plc
Crinetics Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Ipsen SA
Progenics Pharmaceuticals Inc
Strongbridge Biopharma plc
Zucara Therapeutics Inc

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Somatostatin Receptor Type 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Somatostatin Receptor Type 2, with revenue, gross margin and global market share of Somatostatin Receptor Type 2 from 2019 to 2021.
Chapter 3, the Somatostatin Receptor Type 2 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Somatostatin Receptor Type 2 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Somatostatin Receptor Type 2 research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Somatostatin Receptor Type 2
1.2 Classification of Somatostatin Receptor Type 2 by Type
1.2.1 Overview: Global Somatostatin Receptor Type 2 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Somatostatin Receptor Type 2 Revenue Market Share by Type in 2020
1.2.3 CRN-00808
1.2.4 Lanreotide Acetate
1.2.5 PRL-2903
1.2.6 Others
1.3 Global Somatostatin Receptor Type 2 Market by Application
1.3.1 Overview: Global Somatostatin Receptor Type 2 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Global Somatostatin Receptor Type 2 Market Size & Forecast
1.5 Global Somatostatin Receptor Type 2 Market Size and Forecast by Region
1.5.1 Global Somatostatin Receptor Type 2 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Somatostatin Receptor Type 2 Market Size by Region, (2016-2021)
1.5.3 North America Somatostatin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.4 Europe Somatostatin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Somatostatin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.6 South America Somatostatin Receptor Type 2 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Somatostatin Receptor Type 2 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Somatostatin Receptor Type 2 Market Drivers
1.6.2 Somatostatin Receptor Type 2 Market Restraints
1.6.3 Somatostatin Receptor Type 2 Trends Analysis
2 Company Profiles
2.1 Amryt Pharma plc
2.1.1 Amryt Pharma plc Details
2.1.2 Amryt Pharma plc Major Business
2.1.3 Amryt Pharma plc Somatostatin Receptor Type 2 Product and Solutions
2.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amryt Pharma plc Recent Developments and Future Plans
2.2 Crinetics Pharmaceuticals Inc
2.2.1 Crinetics Pharmaceuticals Inc Details
2.2.2 Crinetics Pharmaceuticals Inc Major Business
2.2.3 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Solutions
2.2.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Crinetics Pharmaceuticals Inc Recent Developments and Future Plans
2.3 Daewoong Pharmaceutical Co Ltd
2.3.1 Daewoong Pharmaceutical Co Ltd Details
2.3.2 Daewoong Pharmaceutical Co Ltd Major Business
2.3.3 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product and Solutions
2.3.4 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Daewoong Pharmaceutical Co Ltd Recent Developments and Future Plans
2.4 Ipsen SA
2.4.1 Ipsen SA Details
2.4.2 Ipsen SA Major Business
2.4.3 Ipsen SA Somatostatin Receptor Type 2 Product and Solutions
2.4.4 Ipsen SA Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ipsen SA Recent Developments and Future Plans
2.5 Progenics Pharmaceuticals Inc
2.5.1 Progenics Pharmaceuticals Inc Details
2.5.2 Progenics Pharmaceuticals Inc Major Business
2.5.3 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Solutions
2.5.4 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Progenics Pharmaceuticals Inc Recent Developments and Future Plans
2.6 Strongbridge Biopharma plc
2.6.1 Strongbridge Biopharma plc Details
2.6.2 Strongbridge Biopharma plc Major Business
2.6.3 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product and Solutions
2.6.4 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Strongbridge Biopharma plc Recent Developments and Future Plans
2.7 Zucara Therapeutics Inc
2.7.1 Zucara Therapeutics Inc Details
2.7.2 Zucara Therapeutics Inc Major Business
2.7.3 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product and Solutions
2.7.4 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Zucara Therapeutics Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Somatostatin Receptor Type 2 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Somatostatin Receptor Type 2 Players Market Share
3.2.2 Top 10 Somatostatin Receptor Type 2 Players Market Share
3.2.3 Market Competition Trend
3.3 Somatostatin Receptor Type 2 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Somatostatin Receptor Type 2 Revenue and Market Share by Type (2016-2021)
4.2 Global Somatostatin Receptor Type 2 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2016-2021)
5.2 Somatostatin Receptor Type 2 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Somatostatin Receptor Type 2 Revenue by Type (2016-2026)
6.2 North America Somatostatin Receptor Type 2 Revenue by Application (2016-2026)
6.3 North America Somatostatin Receptor Type 2 Market Size by Country
6.3.1 North America Somatostatin Receptor Type 2 Revenue by Country (2016-2026)
6.3.2 United States Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
6.3.3 Canada Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
6.3.4 Mexico Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Somatostatin Receptor Type 2 Revenue by Type (2016-2026)
7.2 Europe Somatostatin Receptor Type 2 Revenue by Application (2016-2026)
7.3 Europe Somatostatin Receptor Type 2 Market Size by Country
7.3.1 Europe Somatostatin Receptor Type 2 Revenue by Country (2016-2026)
7.3.2 Germany Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.3 France Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.5 Russia Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
7.3.6 Italy Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Somatostatin Receptor Type 2 Revenue by Type (2016-2026)
8.2 Asia-Pacific Somatostatin Receptor Type 2 Revenue by Application (2016-2026)
8.3 Asia-Pacific Somatostatin Receptor Type 2 Market Size by Region
8.3.1 Asia-Pacific Somatostatin Receptor Type 2 Revenue by Region (2016-2026)
8.3.2 China Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.3 Japan Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.4 South Korea Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.5 India Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
8.3.7 Australia Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Somatostatin Receptor Type 2 Revenue by Type (2016-2026)
9.2 South America Somatostatin Receptor Type 2 Revenue by Application (2016-2026)
9.3 South America Somatostatin Receptor Type 2 Market Size by Country
9.3.1 South America Somatostatin Receptor Type 2 Revenue by Country (2016-2026)
9.3.2 Brazil Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
9.3.3 Argentina Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Somatostatin Receptor Type 2 Revenue by Type (2016-2026)
10.2 Middle East & Africa Somatostatin Receptor Type 2 Revenue by Application (2016-2026)
10.3 Middle East & Africa Somatostatin Receptor Type 2 Market Size by Country
10.3.1 Middle East & Africa Somatostatin Receptor Type 2 Revenue by Country (2016-2026)
10.3.2 Turkey Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
10.3.4 UAE Somatostatin Receptor Type 2 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Somatostatin Receptor Type 2 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Somatostatin Receptor Type 2 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Somatostatin Receptor Type 2 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Somatostatin Receptor Type 2 Revenue (USD Million) by Region (2016-2021)
Table 5. Global Somatostatin Receptor Type 2 Revenue Market Share by Region (2021-2026)
Table 6. Amryt Pharma plc Corporate Information, Head Office, and Major Competitors
Table 7. Amryt Pharma plc Major Business
Table 8. Amryt Pharma plc Somatostatin Receptor Type 2 Product and Solutions
Table 9. Amryt Pharma plc Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Crinetics Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 11. Crinetics Pharmaceuticals Inc Major Business
Table 12. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Solutions
Table 13. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Daewoong Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Daewoong Pharmaceutical Co Ltd Major Business
Table 16. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product and Solutions
Table 17. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ipsen SA Corporate Information, Head Office, and Major Competitors
Table 19. Ipsen SA Major Business
Table 20. Ipsen SA Somatostatin Receptor Type 2 Product and Solutions
Table 21. Ipsen SA Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Progenics Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 23. Progenics Pharmaceuticals Inc Major Business
Table 24. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Solutions
Table 25. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Strongbridge Biopharma plc Corporate Information, Head Office, and Major Competitors
Table 27. Strongbridge Biopharma plc Major Business
Table 28. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product and Solutions
Table 29. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Zucara Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 31. Zucara Therapeutics Inc Major Business
Table 32. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product and Solutions
Table 33. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Somatostatin Receptor Type 2 Revenue (USD Million) by Players (2019-2021)
Table 35. Global Somatostatin Receptor Type 2 Revenue Share by Players (2019-2021)
Table 36. Breakdown of Somatostatin Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Somatostatin Receptor Type 2 Players Head Office, Products and Services Provided
Table 38. Somatostatin Receptor Type 2 Mergers & Acquisitions in the Past Five Years
Table 39. Somatostatin Receptor Type 2 New Entrants and Expansion Plans
Table 40. Global Somatostatin Receptor Type 2 Revenue (USD Million) by Type (2016-2021)
Table 41. Global Somatostatin Receptor Type 2 Revenue Share by Type (2016-2021)
Table 42. Global Somatostatin Receptor Type 2 Revenue Forecast by Type (2021-2026)
Table 43. Global Somatostatin Receptor Type 2 Revenue by Application (2016-2021)
Table 44. Global Somatostatin Receptor Type 2 Revenue Forecast by Application (2021-2026)
Table 45. North America Somatostatin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Somatostatin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Somatostatin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Somatostatin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Somatostatin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Somatostatin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Somatostatin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Somatostatin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Somatostatin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Somatostatin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Somatostatin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Somatostatin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Somatostatin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Somatostatin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Somatostatin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Somatostatin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Somatostatin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Somatostatin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Somatostatin Receptor Type 2 Picture
Figure 2. Global Somatostatin Receptor Type 2 Revenue Market Share by Type in 2020
Figure 3. CRN-00808
Figure 4. Lanreotide Acetate
Figure 5. PRL-2903
Figure 6. Others
Figure 7. Somatostatin Receptor Type 2 Revenue Market Share by Application in 2020
Figure 8. Hormonal Disorder Picture
Figure 9. Oncology Picture
Figure 10. Metabolic Disorder Picture
Figure 11. Others Picture
Figure 12. Global Somatostatin Receptor Type 2 Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Somatostatin Receptor Type 2 Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Somatostatin Receptor Type 2 Revenue Market Share by Region (2016-2026)
Figure 15. Global Somatostatin Receptor Type 2 Revenue Market Share by Region in 2020
Figure 16. North America Somatostatin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Somatostatin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Somatostatin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Somatostatin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Somatostatin Receptor Type 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Somatostatin Receptor Type 2 Market Drivers
Figure 22. Somatostatin Receptor Type 2 Market Restraints
Figure 23. Somatostatin Receptor Type 2 Market Trends
Figure 24. Amryt Pharma plc Recent Developments and Future Plans
Figure 25. Crinetics Pharmaceuticals Inc Recent Developments and Future Plans
Figure 26. Daewoong Pharmaceutical Co Ltd Recent Developments and Future Plans
Figure 27. Ipsen SA Recent Developments and Future Plans
Figure 28. Progenics Pharmaceuticals Inc Recent Developments and Future Plans
Figure 29. Strongbridge Biopharma plc Recent Developments and Future Plans
Figure 30. Zucara Therapeutics Inc Recent Developments and Future Plans
Figure 31. Global Somatostatin Receptor Type 2 Revenue Share by Players in 2020
Figure 32. Somatostatin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Somatostatin Receptor Type 2 Revenue Market Share in 2020
Figure 34. Global Top 10 Players Somatostatin Receptor Type 2 Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Somatostatin Receptor Type 2 Revenue Share by Type in 2020
Figure 37. Global Somatostatin Receptor Type 2 Market Share Forecast by Type (2021-2026)
Figure 38. Global Somatostatin Receptor Type 2 Revenue Share by Application in 2020
Figure 39. Global Somatostatin Receptor Type 2 Market Share Forecast by Application (2021-2026)
Figure 40. North America Somatostatin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 41. North America Somatostatin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 42. North America Somatostatin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 43. United States Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Somatostatin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 47. Europe Somatostatin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 48. Europe Somatostatin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 49. Germany Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Somatostatin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Somatostatin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Somatostatin Receptor Type 2 Revenue Market Share by Region (2016-2026)
Figure 57. China Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Somatostatin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 64. South America Somatostatin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 65. South America Somatostatin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Somatostatin Receptor Type 2 Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Somatostatin Receptor Type 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source

---